An application was made by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs.
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates